Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet Clin North Am Exot Anim Pract ; 11(2): 211-28, v, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18406385

RESUMO

The poisoned exotic veterinary patient remains a significant challenge to the clinician. A patient presenting with the history of exposure to a toxin or poison should be considered to have a potentially life-threatening problem. This article details the ABCs of emergency medicine including fluid therapy and discusses the principles of neurologic management. The last part of the article provides the clinician with guidelines for decontamination and critical care management of some of the more common toxicoses in exotic animals.


Assuntos
Serviços Médicos de Emergência/métodos , Hidratação/veterinária , Intoxicação/veterinária , Medicina Veterinária/métodos , Animais , Animais Domésticos , Intoxicação/diagnóstico , Intoxicação/etiologia , Intoxicação/terapia , Especificidade da Espécie
2.
J Vet Intern Med ; 16(2): 208-10, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11899040

RESUMO

Zolpidem is a nonbenzodiazepine hypnotic of the imidazopyridine class that is used to treat insomnia in humans. Zolpidem binds selectively to the benzodiazepine omega-1 receptor and increases the frequency of chloride channel opening, which results in inhibition of neuronal excitation. A retrospective study was conducted of zolpidem ingestion in dogs that were reported to the ASPCA Animal Poison Control Center (APCC) between January 1998 and July 2000. Data analysis included amount ingested, clinical effects, and time of onset of signs. Thirty-three reports of zolpidem ingestion in dogs (ranging in age from 5 months to 16 years) were evaluated. Approximate ingested dosages ranged from 0.24 to 21 mg/kg. Clinical signs reported included ataxia (18 dogs; 54.5%), hyperactivity (10 dogs; 30.3%), vomiting (7 dogs; 21.2%), and lethargy (5 dogs; 15.2%), as well as panting, disorientation, nonspecific behavior disorder, and hypersalivation (4 dogs each sign; 12.1%). Other signs reported include tachycardia, tremors, apprehension, vocalization, hypersalivation, weakness, and hyperesthesia. In 85% percent of reports, clinical signs developed within 1 hour and usually resolved within 12 hours. Although central nervous system (CNS) depression is reported as a primary effect of zolpidem in humans and would also be expected in dogs, information obtained from this study indicates that some dogs may exhibit a paradoxical excitation reaction. This effect appears to vary among individual dogs.


Assuntos
Doenças do Cão/induzido quimicamente , Hipnóticos e Sedativos/intoxicação , Piridinas/intoxicação , Animais , Ataxia/induzido quimicamente , Ataxia/veterinária , Doenças do Cão/diagnóstico , Doenças do Cão/patologia , Cães , Feminino , Humanos , Hipercinese/induzido quimicamente , Hipercinese/veterinária , Hipnóticos e Sedativos/administração & dosagem , Masculino , Intoxicação/patologia , Intoxicação/veterinária , Piridinas/administração & dosagem , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Fases do Sono , Síndrome , Vômito/induzido quimicamente , Vômito/veterinária , Zolpidem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA